Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Hepatol. Mar 27, 2025; 17(3): 103261
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.103261
Figure 1
Figure 1 Study flowchart. The flowchart illustrating the screening and grouping of 963 transjugular intrahepatic portosystemic shunt-treated portal hypertension patients. A total of 148 patients were excluded whereas 815 were included. Patients were divided based on portal pressure gradient reduction into group A and group B, with 357 and 305 patients, respectively, after propensity score matching. TIPS: Transjugular intrahepatic portosystemic shunt; HCC: Hepatocellular carcinoma; PSM: Propensity score matching.